Screener
Absci Corporation ABSI External preclinical and clinical development — R&D
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Absci Corporation in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Absci Corporation’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:24 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001672688-26-000088
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Drug creation programs and platform (1) | $6,083 | $3,992 |
| External preclinical and clinical development (2) | 4,287 | 2,684 |
| Personnel (3) | 9,246 | 9,865 |
| Stock-based compensation | 4,380 | 4,943 |
| General & administrative | 4,334 | 4,338 |
| Depreciation and amortization | 2,728 | 3,072 |
| Other (gain)/loss, net (4) | 3 | 14 |
| Total operating expenses | $31,061 | $28,908 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Absci Corporation's external preclinical and clinical development — R&D?
- Absci Corporation (ABSI) reported external preclinical and clinical development — R&D of $4.29M in Q1 2026.
- How has Absci Corporation's external preclinical and clinical development — R&D changed year-over-year?
- Absci Corporation's external preclinical and clinical development — R&D increased by 59.7% year-over-year, from $2.68M to $4.29M.
- What does external preclinical and clinical development — R&D mean?
- This metric represents the direct research and development expenditures allocated to the external preclinical and clinical development segment. It captures the investment required to advance biologic drug candidates through experimental validation and early-stage clinical trials. Monitoring this spend provides insight into the company's commitment to scaling its proprietary therapeutic pipeline and the associated costs of externalizing development activities.
Ask your AI about Absci Corporation's external preclinical and clinical development — r&d.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude